[
  {
    "title": "圣诺生物股东减持58.08万股 套现1489.15万 2022年前三季度公司净利3900.58万",
    "href": "http://stock.jrj.com.cn/2022/12/27195137241443.shtml",
    "datetime": "2022-12-27 19:51:28",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：熔拓聚兴以集中竞价累计减持0.726%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/27173137240949.shtml",
    "datetime": "2022-12-27 17:31:27",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：减持数过半 董事王晓莉累计减持20万股",
    "href": "http://stock.jrj.com.cn/2022/11/29182037175190.shtml",
    "datetime": "2022-11-29 18:20:25",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：2名董高完成减持合计14.875万股",
    "href": "http://stock.jrj.com.cn/2022/11/29181837175126.shtml",
    "datetime": "2022-11-29 18:18:43",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：醋酸加尼瑞克原料药获批上市",
    "href": "http://stock.jrj.com.cn/2022/11/07180337117787.shtml",
    "datetime": "2022-11-07 18:03:35",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：3名董高拟减持合计不超53.65万股",
    "href": "http://stock.jrj.com.cn/2022/11/03181837110436.shtml",
    "datetime": "2022-11-03 18:18:23",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：醋酸奥曲肽原料药获得欧洲药品质量管理局认证",
    "href": "http://stock.jrj.com.cn/2022/10/31183437100638.shtml",
    "datetime": "2022-10-31 18:34:54",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：第三季度净利增7.05%至2036.53万元",
    "href": "http://stock.jrj.com.cn/2022/10/27215637091658.shtml",
    "datetime": "2022-10-27 21:56:18",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：减持期过半 熔拓聚兴已减持4.2053万股",
    "href": "http://stock.jrj.com.cn/2022/09/27172437025216.shtml",
    "datetime": "2022-09-27 17:24:21",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：醋酸阿托西班注射液通过注射剂一致性评价",
    "href": "http://stock.jrj.com.cn/2022/09/13171136991560.shtml",
    "datetime": "2022-09-13 17:11:00",
    "code": "688117"
  },
  {
    "title": "圣诺生物披露2022年半年报 实现营收1.68亿元",
    "href": "http://stock.jrj.com.cn/2022/08/25092736934062.shtml",
    "datetime": "2022-08-25 09:27:02",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117)：增加预计2022年度日常关联交易额度",
    "href": "http://stock.jrj.com.cn/2022/08/25085736933962.shtml",
    "datetime": "2022-08-25 08:57:03",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)半年度净利润1864.05万元、同比下降22.36%",
    "href": "http://stock.jrj.com.cn/2022/08/24215736932345.shtml",
    "datetime": "2022-08-24 21:57:56",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：醋酸奥曲肽注射液拟中选第七批全国药品集采",
    "href": "http://stock.jrj.com.cn/2022/07/13191236808463.shtml",
    "datetime": "2022-07-13 19:12:50",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：拟使用不超2亿元闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/07/11182436799879.shtml",
    "datetime": "2022-07-11 18:24:30",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：熔拓创新等多名股东拟合计减持不超5.05%股份",
    "href": "http://stock.jrj.com.cn/2022/06/06171536706064.shtml",
    "datetime": "2022-06-06 17:15:39",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：2730.1万股首发限售股6月6日解禁 占比34.13%",
    "href": "http://stock.jrj.com.cn/2022/05/25175336678203.shtml",
    "datetime": "2022-05-25 17:53:17",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：2021年度权益分派10派3元 股权登记日为5月31日",
    "href": "http://stock.jrj.com.cn/2022/05/24195736675271.shtml",
    "datetime": "2022-05-24 19:57:25",
    "code": "688117"
  },
  {
    "title": "圣诺生物2022年第一季度净利1429.29万 较上年同期增长22.64%",
    "href": "http://stock.jrj.com.cn/2022/05/03145036543570.shtml",
    "datetime": "2022-05-03 14:50:39",
    "code": "688117"
  },
  {
    "title": "圣诺生物2021年净利6125.28万同比增长2.09% 董事长文永均薪酬64.08万",
    "href": "http://stock.jrj.com.cn/2022/04/29221136507993.shtml",
    "datetime": "2022-04-29 22:11:49",
    "code": "688117"
  },
  {
    "title": "圣诺生物披露2022年一季报 实现营收8074.48万元",
    "href": "http://stock.jrj.com.cn/2022/04/26095836472900.shtml",
    "datetime": "2022-04-26 09:58:15",
    "code": "688117"
  },
  {
    "title": "圣诺生物披露2021年年报 实现营收3.87亿元",
    "href": "http://stock.jrj.com.cn/2022/04/26095736472902.shtml",
    "datetime": "2022-04-26 09:57:47",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：一季度净利润增22.64%至1429.29万元",
    "href": "http://stock.jrj.com.cn/2022/04/25222236468953.shtml",
    "datetime": "2022-04-25 22:22:40",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：2021年净利增2.09%至6125.28万元 拟10派3元",
    "href": "http://stock.jrj.com.cn/2022/04/25222136468955.shtml",
    "datetime": "2022-04-25 22:21:04",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：“年产395千克多肽原料药生产线项目”延期",
    "href": "http://stock.jrj.com.cn/2022/04/12180736316154.shtml",
    "datetime": "2022-04-12 18:07:18",
    "code": "688117"
  },
  {
    "title": "圣诺生物2021年净利6186.33万同比增长3.11% 各项业务稳定发展",
    "href": "http://stock.jrj.com.cn/2022/02/25213034468460.shtml",
    "datetime": "2022-02-25 21:30:39",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：83.428万股限售股将于12月3日解禁上市",
    "href": "http://stock.jrj.com.cn/2021/11/25170133919311.shtml",
    "datetime": "2021-11-25 17:01:54",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：第三季度净利润升83.89%至1902.49万元",
    "href": "http://stock.jrj.com.cn/2021/10/27193733763578.shtml",
    "datetime": "2021-10-27 19:37:37",
    "code": "688117"
  },
  {
    "title": "圣诺生物2021年半年度净利2400.9万元 同比净利减少23.32%",
    "href": "http://stock.jrj.com.cn/2021/08/31123233359925.shtml",
    "datetime": "2021-08-31 12:32:37",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：上半年净利降23.32%至2400.898万元",
    "href": "http://stock.jrj.com.cn/2021/08/30180433353427.shtml",
    "datetime": "2021-08-30 18:04:24",
    "code": "688117"
  },
  {
    "title": "港股IPO|圣诺生物递表拟香港上市，近两年来尚未取得任何收入",
    "href": "http://stock.jrj.com.cn/2021/07/16152033107502.shtml",
    "datetime": "2021-07-16 15:20:27",
    "code": "688117"
  },
  {
    "title": "圣诺生物上市首日涨266% IPO募3.6亿民生证券赚0.5亿",
    "href": "http://stock.jrj.com.cn/2021/06/03151832869217.shtml",
    "datetime": "2021-06-03 15:18:00",
    "code": "688117"
  },
  {
    "title": "今日上市：普联软件、圣诺生物",
    "href": "http://stock.jrj.com.cn/2021/06/03090032867686.shtml",
    "datetime": "2021-06-03 09:00:00",
    "code": "688117"
  },
  {
    "title": "圣诺生物：将于2021年6月3日在上海证券交易所科创板科创板上市",
    "href": "http://stock.jrj.com.cn/2021/06/02073332861034.shtml",
    "datetime": "2021-06-02 07:33:59",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：将于6月3日在科创板上市",
    "href": "http://stock.jrj.com.cn/2021/06/01191332858619.shtml",
    "datetime": "2021-06-01 19:13:36",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：遭弃购7528股 由主承销商包销",
    "href": "http://stock.jrj.com.cn/2021/05/27220032832186.shtml",
    "datetime": "2021-05-27 22:00:08",
    "code": "688117"
  },
  {
    "title": "【兑奖啦】欢乐家、普联软件、科创板圣诺生物网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2021/05/25215132818694.shtml",
    "datetime": "2021-05-25 21:51:15",
    "code": "688117"
  },
  {
    "title": "【兑奖啦】科创板圣诺生物网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2021/05/25201332818248.shtml",
    "datetime": "2021-05-25 20:13:05",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)IPO网上中签结果出炉：中签号共1.52万个",
    "href": "http://stock.jrj.com.cn/2021/05/25191732818008.shtml",
    "datetime": "2021-05-25 19:17:42",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：网上发行最终中签率为0.02649039%",
    "href": "http://stock.jrj.com.cn/2021/05/24222932812806.shtml",
    "datetime": "2021-05-24 22:29:00",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)首次公开发行2000万股 发行价17.9元/股",
    "href": "http://stock.jrj.com.cn/2021/05/20191232788677.shtml",
    "datetime": "2021-05-20 19:12:57",
    "code": "688117"
  },
  {
    "title": "圣诺生物(688117.SH)：网上路演时间5月21日14:00-17:00",
    "href": "http://stock.jrj.com.cn/2021/05/19191032782872.shtml",
    "datetime": "2021-05-19 19:10:10",
    "code": "688117"
  },
  {
    "title": "圣诺生物、皓元医药、科汇股份、博力威、和辉光电科创板IPO注册生效",
    "href": "http://stock.jrj.com.cn/2021/04/29092032477947.shtml",
    "datetime": "2021-04-29 09:20:19",
    "code": "688117"
  },
  {
    "title": "证监会同意圣诺生物、科汇股份、皓元医药、博力威科创板IPO注册",
    "href": "http://stock.jrj.com.cn/2021/04/27201732465222.shtml",
    "datetime": "2021-04-27 20:17:00",
    "code": "688117"
  },
  {
    "title": "中止审核情形消除 圣诺生物科创板IPO恢复“提交注册”状态",
    "href": "http://stock.jrj.com.cn/2021/04/15090732377182.shtml",
    "datetime": "2021-04-15 09:07:49",
    "code": "688117"
  },
  {
    "title": "不重研发重销售 圣诺生物凭什么上科创板",
    "href": "http://stock.jrj.com.cn/2020/12/24080931558271.shtml",
    "datetime": "2020-12-24 08:09:15",
    "code": "688117"
  },
  {
    "title": "圣诺生物：今年科创板过会第197家 民生证券过10单",
    "href": "http://stock.jrj.com.cn/2020/12/14111131485547.shtml",
    "datetime": "2020-12-14 11:11:00",
    "code": "688117"
  },
  {
    "title": "圣诺生物、迈信林12月11日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2020/12/02202031394495.shtml",
    "datetime": "2020-12-02 20:20:00",
    "code": "688117"
  },
  {
    "title": "产品销售依赖西藏易明？ 圣诺生物回复二轮问询",
    "href": "http://stock.jrj.com.cn/kcb/2020/11/17011731295097.shtml",
    "datetime": "2020-11-17 01:17:40",
    "code": "688117"
  },
  {
    "title": "回复首轮问询 圣诺生物称产品毛利率存在下降风险",
    "href": "http://stock.jrj.com.cn/kcb/2020/10/22032231104123.shtml",
    "datetime": "2020-10-22 03:22:28",
    "code": "688117"
  },
  {
    "title": "圣诺生物再次变道科创板IPO：研发费用率较低 科创属性不凸显 | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/10/20102231090320.shtml",
    "datetime": "2020-10-20 10:22:36",
    "code": "688117"
  },
  {
    "title": "圣诺生物冲刺科创板 二股东乐普医疗今年披露持股比例疑错误",
    "href": "http://stock.jrj.com.cn/2020/07/03213230136755.shtml",
    "datetime": "2020-07-03 21:32:26",
    "code": "688117"
  },
  {
    "title": "成都圣诺生物科技股份有限公司变更上市板块 拟赴科创板IPO",
    "href": "http://stock.jrj.com.cn/2020/05/27103329776953.shtml",
    "datetime": "2020-05-27 10:33:25",
    "code": "688117"
  }
]